Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project [Phase 1]
Phase 1 COLPAN trial evaluating near-infrared technology to assist laparoscopic resection of pancreatic lesions has completed, including pan…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA [Phase 2]
Phase 2 trial assessing safety and activity of G-202 in PSMA-expressing clear cell renal cell carcinoma completed.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating the combination of Interleukin-2 with sorafenib for unresectable or metastatic clear cell renal cell carcinoma and …
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery [Phase 3]
Phase 3 trial evaluating sunitinib malate or sorafenib tosylate for kidney cancer post-surgery has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) [Phase 1, Phase 2]
This document describes an early-phase dose-finding and safety/efficacy study of radium-223 dichloride (Xofigo) in patients with clear-cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without recombinant interferon alfa-2b in patients with metastatic renal cell carcinoma; results …
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus [Phase 2]
This Phase 2 trial examined biomarkers before and after nephrectomy in patients with locally advanced or metastatic renal cell carcinoma tre…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma
A completed study validating a predictive nomogram for response or resistance to targeted therapies in metastatic clear cell renal cell carc…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: AMG 172 First in Human Study in Patients With Kidney Cancer [Phase 1]
A first-in-human Phase 1 trial of AMG 172 in patients with kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat in combination with bevacizumab for unresectable or metastatic renal cell carcinoma has completed with…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer [Phase 2]
Phase II study of Lutetium-177 labeled girentuximab for metastatic clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial investigating bevacizumab, sorafenib tosylate, and temsirolimus in metastatic kidney cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update for Tandutinib in patients who had surgery for metastatic renal cell carcinoma, including clear cell and recurrent dise…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC [Phase 2]
This Phase 2 trial assesses dovitinib as a first-line treatment for clear cell renal cell carcinoma. It also analyzes correlations between g…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of CCI-779 (temsirolimus) and bevacizumab in metastatic or unresectable kidney cancer has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Rotating Pazopanib and Everolimus to Avoid Resistance [Phase 2]
A Phase 2 study examining rotating pazopanib and everolimus to prevent therapy resistance in clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer [Phase 2]
A Phase 2 trial comparing AZD2014 and Everolimus in metastatic clear cell renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 [NA]
The study completed and evaluated whether sorafenib affects the uptake of radiolabeled bevacizumab or girentuximab (cG250) in clear cell ren…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer [Phase 2]
Phase 2 trial of cediranib (AZD2171) in patients with refractory metastatic kidney cancer was terminated, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer [Phase 1]
A Phase 1 dose-escalation trial evaluating the combination of everolimus and dovitinib in metastatic clear cell renal cell carcinoma has com…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating sorafenib in combination with interferon alfa-2b for locally advanced or metastatic renal cell carcinoma; …
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. [Phase 1]
Phase 1 study of MDX-1411 given every 14 days with pre-medications in clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma [Phase 2]
This update summarizes results from a Phase 2 trial evaluating the combination of bevacizumab (Avastin) and everolimus (RAD001) for advanced…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
This Phase 2 clinical trial evaluated the combination of sorafenib and interferon alfa in patients with metastatic or unresectable renal cel…